Dr. Melissa Norberg is the National Clinical Services and Evaluation Manager at the National Cannabis Prevention and Information Centre (NCPIC). She carried out her postgraduate training in clinical psychology at the University of Wisconsin-Milwaukee. She completed her predoctoral internship specializing in the treatment of anxiety and substance use disorders at the University of Mississippi Medical Center and her postdoctoral fellowship at the Anxiety Disorders Center at the Institute of Living/Hartford Hospital. Dr Norberg is a registered psychologist in the state of NSW and a member of the Clinical College of the Australian Psychological Association. Previously, she was vice-chair of the Women's Special Interest Group for the Association of Behavioral and Cognitive Therapy. She is currently a co-investigator on NHMRC funded trials examining interventions for ecstasy use and cannabis withdrawal. Dr Norberg's primary clinical and research interests are in the psychopathology and cognitive-behavioural treatment of comorbid anxiety and substance use disorders and in extending treatment outcome to include quality of life assessment. As such, she joined NCPIC to increase the centre's capacity to disseminate evidence-based cannabis use interventions and to develop innovative interventions. Dr Norberg will be leading the Clinical Services and Evaluation Team in these efforts, along with other projects.

Dr. Melissa Norberg’s research interests include: Illegal Drugs; Behaviour Therapy; Mental Processes; Alcohol; Tobacco